Generics
Padagis invests USD36m to expand manufacturing in Minneapolis
29 October 2025 - US-based generic pharmaceuticals company Padagis announced on Tuesday that it is investing more than USD36m to expand its manufacturing operations in Minneapolis, Minnesota.This incl...
Newbury Pharmaceuticals gains Danish approval for generic ivermectin cream
23 October 2025 - Swedish pharmaceutical company Newbury Pharmaceuticals AB (STO:NEWBRY) announced on Thursday that it has been granted Marketing Authorization for Ivermectin Newbury 10 mg/g cream in ...
BioArctic and Eisai's Leqembi Iqlik (lecanemab-irmb) selected as one of TIME's best innovations of 2025
14 October 2025 - Swedish research-based biopharma company BioArctic AB (STO:BIOA-B) and its Japanese partner Eisai Co Ltd (TYO:4523) announced on Tuesday that Leqembi Iqlik, a subcutaneous autoinject...
Esperion settles with Dr. Reddy's Laboratories on NEXLETOL and NEXLIZET generics
3 October 2025 - US commercial stage biopharmaceutical company Esperion Therapeutics Inc (NASDAQ:ESPR) on Friday announced a settlement with Indian pharmaceutical company Dr. Reddy's Laboratories...
Mint Pharmaceuticals forms distribution partnership with Bayer Canada
26 September 2025 - Canadian generic pharmaceuticals company Mint Pharmaceuticals Inc announced on Thursday that it has agreed a new distribution partnership with Bayer Canada, a subsidiary of German ...
Padagis collaborates with The Naloxone Project to address opioid overdose crisis
24 September 2025 - Generic pharmaceuticals company Padagis announced on Tuesday a new partnership with The Naloxone Project (TNP), a clinician-led, nonprofit organisation dedicated to transforming th...